申请人:EICOSIS LLC
公开号:US20170174665A1
公开(公告)日:2017-06-22
The invention discloses a new series of inhibitors of soluble epoxide hydrolase (sEH) with improved physical properties that enhance their druglikeness to treat sEH associated diseases such as chronic diabetic neuropathic pain.